Hepatitis Test Diagnosis Market, by Disease Type (Hepatitis B, HCV, HAV, HDV), Technology (ELISA, RDT, PCR, Transcription Mediated Amplification), End User (Hospitals, Diagnostic Laboratories, Blood Banks, Nursing Homes), and Regional (North America, Europe, Asia Pacific, Middle East and Africa, South America), Forecast, 2021–2030

The Hepatitis Test Diagnosis Market is projected to grow from USD XX billion in 2021 to USD XX billion in 2030 at a CAGR of XX%. Hepatitis is recognized by the inflammation of the liver, which is of different types. It is also distinguished on the different types of viruses, Hepatitis A, B, and C. Diagnosis of this disease is done through sample blood testing for each virus. There is also a method of testing for antibodies related to the virus. A method of diagnosing the type of hepatitis also involves testing the genetic material or proteins in the body parts with virus. The rising prevalence of hepatitis disease across the globe and the urgency for a diagnostic system to determine the type of virus drive the hepatitis test diagnosis market.

fig 1

COVID-19 Impact on Hepatitis Test Diagnosis Market

COVID-19 is an unparalleled global public health emergency that has impacted almost every industry, and the long-term strains are projected to affect the industry growth during the forecast period. Pertinent research brings forth our research system to ensure that underlying COVID-19 issues are not overlooked by delineating potential paths forward. The report delivers topical insights on COVID-19 considering the alterations in consumer behavior and demand, purchasing trends, re-framing the supply chain, repercussions of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and highlights the COVID-19 impact on the market.               

Latest Trends

The World Health Organization (WHO) views hepatitis as the main reason for liver cancer. High prevalence of the disease is driving the demand for advanced diagnostic tools. Hence, a paradigm shift from conventional tools to molecular diagnosis has increased the procedural efficiency and also has reduced the procrastination time. Molecular diagnostics involves genetic tests to confirm the precise strain of the causative virus. The nucleic acid assays used include Hepatitis C Virus (HCV), Ribonucleic acid (RNA) and Hepatitis B Virus (HBV) deoxyribonucleic acid (DNA) analysis tests. Hence, the availability of such advanced detection techniques is escalating the overall hepatitis test diagnosis market growth.

Driving Factors

Awareness about the benefits of testing of hepatitis virus helping pinpoint the correct course of action and disease prevention is the significant factor escalating the hepatitis test diagnosis market growth. Furthermore, fluctuating lifestyles and food consumption habits, coupled with rising side effect of the medication, and excessive intake of alcohol contribute to hepatitis test diagnosis market. Rising incidences of viral hepatitis and autoimmune diseases, customer purchasing power, expanding medical tourism, and the growing leverage of large demography of undiagnosed population are the major factors driving the hepatitis test diagnosis market. Furthermore, growing technological advancements and modernization in the healthcare sector, rising R&D activities in the healthcare sector and rising emerging markets with an increasing geriatric population base will further create new opportunities for the hepatitis test diagnosis market during the forecast period.

Restraining Factors

However, rising cost of NAT (nucleic acid amplification testing) and growing absence of any issuance of compulsory orders by authorities in developing countries regarding the testing for hepatitis virus are the major factors among others which will impede the market growth, and will further challenge the growth of hepatitis test diagnosis market during the forecast period.

Market Segmentation

The global hepatitis test diagnosis market is segmented into by disease type, technology, end user, and region.

Hepatitis Test Diagnosis Market, by Disease Type

Based on disease type, the hepatitis test diagnosis market is segmented into Hepatitis B, Hepatitis C Virus (HCV), Hepatitis A Virus (HAV) and Hepatitis D Virus (HDV).

The hepatitis B segment is expected to hold the largest market share during the forecast period. This can primarily be attributed to the rising incidence of hepatitis B, availability of a large number of hepatitis B diagnostic screenings, and the increasing adoption of NAT test in Hepatitis B Virus (HBVblood test.

Hepatitis Test Diagnosis Market, by Technology

Based on technology, the hepatitis test diagnosis market is segmented into Enzyme Linked Immunoassay (ELISA), Rapid Diagnostic Tests (RDT), Polymerase Chain Reaction (PCR, and Transcription Mediated Amplification.

The ELISA segment is expected to hold the largest share of the global hepatitis test diagnosis market during the forecast period. The large share of ELISA can be attributed to wide leverage of this test in healthcare practices to diagnose hepatitis.

Rapid diagnostics test (RDT) segment is expected to deliver grow with the highest CAGR during the forecast period. High growth of rapid diagnostics test segment can be sourced to the low expenditure on this test type, its superior analytical sensitivity, and its uncanny ability to spot all known 11 subtypes of HBsAg.

Hepatitis Test Diagnosis Market, by End User

Based on end user, the hepatitis test diagnosis market is segmented into hospitals, diagnostic laboratories, blood banks, and nursing homes.

The hospital and diagnostics laboratories segment is the highest CAGR during the forecast period. This can fundamentally be attributed to the rising patient population, increase in medicare reimbursement for clinical tests performed in hospitals, and the rising emergence of advanced diagnostic tests.

Hepatitis Test Diagnosis Market, by Region

Based on region, the hepatitis test diagnosis market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and South America. North America is expected to hold the largest share of the global hepatitis test diagnosis market during the forecast period. The large contribution of the North America region is mainly attributed to factors such as the developed healthcare systems in the US and Canada, growing traction of advanced technologies, and the presence of a large number of leading national wellness laboratories.

Asia Pacific region is expected to grow at the highest CAGR during the forecast period. The growth of the hepatitis test diagnosis market in Asia pacific is driven by the rampant spread of hepatitis infections, increased healthcare expenditure by a voluminous population base, and rapid transformation of healthcare infrastructure.

fig 2

Key Developments

  • March 2020- FDA cleared the Alinity m system for use with Abbott’s HCV (hepatitis C) assay.
  • March 2020, US-based Danaher Corporation acquired biopharma business of General Electric Company. The newly acquired business is expected to operate under the name of Cytvia. This acquisition is anticipated to expand the product portfolio of Danaher in the biopharma segment.

Key Industry Players

The hepatitis test diagnosis market is dominated by few global players which are basically rivals on the basis of technological innovations.

List of Key Players Profiled

  • Abbott
  • F. Hoffmann La-Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Siemens AG
  • Danaher
  • DiaSorin S.p.A.
  • QIAGEN
  • Grifols, S.A.
  • Hologic Inc
  • MedMira Inc

Market Segmentation

By Disease Type:

  • Hepatitis B
  • HCV
  • HAV
  • HDV

By Technology:

  • ELISA
  • RDT
  • PCR
  • Transcription Mediated Amplification

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Nursing Homes

By Region:

North America

  • North America, by Country
    • U.S.
    • Canada
    • Mexico
  • North America, by Disease Type
  • North America, by Technology
  • North America, by End User

Europe

  • Europe, by Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Europe, by Disease Type
  • Europe, by Technology
  • Europe, by End User

Asia Pacific

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Asia Pacific, by Disease Type
  • Asia Pacific, by Technology
  • Asia Pacific, by End User

Middle East and Africa

  • Middle East and Africa, by Country
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East and Africa
  • Middle East and Africa, by Disease Type
  • Middle East and Africa, by Technology
  • Middle East and Africa, by End User

South America

  • South America, by Country
    • Brazil
    • Argentina
    • Rest of South America
  • South America, by Disease type
  • South America, by Technology
  • South America, by End-User

FAQ’s Answered in the Report

  • In the global hepatitis test diagnosis industry, what are the most important regional markets?
  • What is the market segmentation based on type?
  • What is the market segmentation dependent on end-user?
  • What are the different phases of the global industry's value chain?
  • What are the major drivers and threats in the global hepatitis test diagnosis market?
  • Who are the main players in the global industry and what is their structure?
  • What level of rivalry does the global industry have?
  • What are the profit margins in the hepatitis test diagnosis industry?

Objectives of this report:

  • To estimate market size for hepatitis test diagnosis market on regional and global basis.
  • To identify major segments in hepatitis test diagnosis market and evaluate theirmarket shares and demand.
  • To provide a competitive scenario for the hepatitis test diagnosis market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of hepatitis test diagnosis market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Provides niche insights for decision about every possible segment helping in strategic decision making process.
  • Market size estimation of the hepatitis test diagnosis market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the hepatitis test diagnosis market.

Customization:

This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis

For more information, contact: sales@quincemarketinsights.com